Ÿ¹ÌÇÃ·ç ½ÃÀå : Á¦Çüº°, ¾àÁ¦ À¯Çüº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Tamiflu Market, By Dosage Form, By Drug Type, By Indication, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1584097
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 322 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,452,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,370,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,741,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

Ÿ¹ÌÇÃ·ç ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 19¾ï 2,032¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGR 3.40%·Î È®´ë

Ÿ¹ÌÇÃ·ç ½ÃÀå - ½ÃÀå ¿ªÇÐ

¼¼°èÀÇ °èÀý¼º ÀÎÇ÷翣ÀÚÀÇ Áøº¸¿Í COVID-19 ÆÒµ¥¹Í½ÃÀÇ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁø

Ÿ¹ÌÇ÷ç(¿À¼¿Å¸¹Ìºñ¸£ Àλ꿰)´Â Ç×¹ÙÀÌ·¯½ºÁ¦·Î »ýÈÄ 2ÁÖ ÀÌ»óµÈ »ýÈÄ 2ÁÖ À̳»¿¡ µ¶°¨ Áõ»óÀÌ ³ªÅ¸³­ ȯÀÚ¸¦ ´ë»óÀ¸·Î ±Þ¼º, ¹«Áõ»ó ÀÎÇ÷翣ÀÚ AÇü ¹× BÇü, µÅÁö ÀÎÇ÷翣ÀÚ(H1N1)ÀÇ Ä¡·á¿¡ ÀûÀÀÁõÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ĸ½¶°ú °æ±¸¿ë ÇöŹ¾× µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. Ÿ¹ÌÇ÷ç(¿À¼¿Å¸¹Ìºñ¸£ Àλ꿰) ½ÃÀåÀº ºñ±³Àû °¡º­¿î ºÎÀÛ¿ëÀ¸·Î ÀÎÇØ Àü ¼¼°è °èÀý¼º µ¶°¨ À¯Çà Áõ°¡¿Í COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ Áß ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¸¹Àº Á¦¾à»çµéÀÌ ¿À¼¿Å¸¹Ìºñ¸£ Àλ꿰ÀÇ Á¦³×¸¯ ÀǾàǰÀ» Ãâ½ÃÇϰí ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ÿ¹ÌÇ÷ç´Â AÇü, BÇü, µÅÁö ÀÎÇ÷翣ÀÚ Ä¡·á¿¡ ÀûÀÀÁõÀ» °¡Áö°í ÀÖÀ¸¹Ç·Î Àü ¼¼°è ÀÎÇ÷翣ÀÚ È¯ÀÚ Áõ°¡´Â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2021³â 11¿ù º¸°í¼­¿¡ µû¸£¸é 2020³â Àü ¼¼°è¿¡¼­ 300¸¸-500¸¸ ¸íÀÇ ÁßÁõ µ¶°¨ ȯÀÚ°¡ ¹ß»ýÇß´Ù°í ÇÕ´Ï´Ù.

Tamiflu ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÌ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 3.40%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¾à¹° À¯Çüº°·Î´Â Á¦³×¸¯ ÀǾàǰÀÌ 22023³â °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Á¦Çüº°·Î´Â 2023³â ĸ½¶ÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ 1À§

Ÿ¹ÌÇÃ·ç ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

Ÿ¹ÌÇÃ·ç ¼¼°è ½ÃÀåÀº Á¦Çü, ¾à¹° À¯Çü, ÀûÀÀÁõ, À¯Åë ä³Î, Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.

¾à¹°ÀÇ À¯Çü¿¡ µû¶ó ½ÃÀåÀº ¿À¸®Áö³Î ÀǾàǰ°ú Á¦³×¸¯ ÀǾàǰÀÇ µÎ °¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦³×¸¯ ÀǾàǰÀº °èÀý¼º µ¶°¨ Ä¡·á¿¡¼­ ¿À¼¿Å¸¹Ìºñ¸£ Àλ꿰¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ Áß ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ÿ¹ÌÇ÷çÀÇ Á¦³×¸¯Àº º¸´Ù ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î ´Ù¾çÇÑ È¯ÀÚ¿Í ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àú·ÅÇÑ °¡°Ý°ú ¿À¸®Áö³Î ÀǾàǰ°ú µ¿µîÇÑ È¿´ÉÀº ƯÈ÷ ºñ¿ë¿¡ ¹Î°¨ÇÑ ÀÇ·á ¸ðµ¨À» °¡Áø Áö¿ª¿¡¼­ Á¦³×¸¯ ÀǾàǰÀ» ¼±È£ÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¸¹ÌÇ÷çÀÇ Æ¯Çã°¡ ¸¸·áµÈ ÈÄ ¸¹Àº Á¦¾àȸ»çµéÀÌ Á¦³×¸¯ ÀǾàǰÀ» Ãâ½ÃÇϸ鼭 ½ÃÀå °æÀïÀÌ Ä¡¿­ÇØÁ® °¡°ÝÀÌ ´õ¿í ³·¾ÆÁö°í Á¢±Ù¼ºÀÌ ³ô¾ÆÁ³½À´Ï´Ù.

½ÃÀåÀº Á¦Çü¿¡ µû¶ó ĸ½¶°ú Çöʾ×À¸·Î ³ª´¹´Ï´Ù. ĸ½¶Àº µ¶°¨ Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ¹Ç·Î ¿¹Ãø ±â°£ Áß ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ĸ½¶Àº Æí¸®Çϰí Åõ¿©°¡ ¿ëÀÌÇϸç ÇÕº´Áõ ¾øÀÌ µ¶°¨ Ä¡·á¿¡ ÀÖÀ¸¸ç, ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ä¸½¶Àº ÇöŹ¾×¿¡ ºñÇØ ¾ÈÁ¤¼ºÀÌ ³ô°í º¸Á¸ ±â°£ÀÌ ±æ¾î ºñÃà ¹× À¯Åë¿¡ ÀûÇÕÇÕ´Ï´Ù. ¹Ý¸é °æ±¸¿ë Çöʾ×Àº ÀϹÝÀûÀ¸·Î À¯¾Æ³ª ƯÁ¤ ÁúȯÀ» ¾Î°í Àִ ȯÀÚ µî ĸ½¶À» »ïų ¼ö ¾ø´Â ȯÀÚ¿¡°Ô¸¸ »ç¿ëµË´Ï´Ù. Ÿ¹ÌÇ÷ç´Â ÀÌ·¯ÇÑ »ç¶÷µéÀÇ Á¢±Ù¼ºÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏÁö¸¸, °æ±¸¿ë ÇöŹ¾×¿¡ ´ëÇÑ ¼ö¿ä´Â ¿©ÀüÈ÷ ĸ½¶¿¡ ºñÇØ ³·À¸¸ç ÈÄÀÚ ½ÃÀå ¿ìÀ§°¡ °­È­µÇ°í ÀÖ½À´Ï´Ù.

Ÿ¹ÌÇÃ·ç ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ Ÿ¹ÌÇÃ·ç ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ±× ÁÖ¿ä ÀÌÀ¯´Â ½ÃÀå Á¡À¯À²ÀÌ ³ô°í ÇâÈÄ µ¶°¨ ½ÃÁðÀ» ´ëºñÇÑ Å¸¹ÌÇÃ·ç ºñÃà·®ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ Á¤ºÎ´Â 2022³â 12¿ù 21ÀÏ ¹Ì±¹ º¸°Çº¹ÁöºÎ(HHS)°¡ Àü·«Àû Áغñ ¹× ´ëÀÀ±¹(ASPR)°ú ÇÔ²² 2022³â µ¶°¨ ½ÃÁ𠵿¾È ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Å¸¹ÌÇ÷縦 Ãß°¡ ºñÃàÇÒ °ÍÀ̶ó°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ´Â Àü·«Àû ±¹°¡ºñÃà(SNS)À» ÅëÇØ ÀÌ·ç¾îÁ³½À´Ï´Ù. Á¤ºÎ´Â ASPR Áö¿ªÆÀ°ú Çù·ÂÇÏ¿© SNSÀÇ Å¸¹ÌÇÃ·ç ¹èÆ÷ ¿äûÀ» Æò°¡ÇÏ¿© ÁÖ, ÁØÁÖ ¹× ºÎÁ·ÀÌ ÇÊ¿äÇÑ Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â ÇÑÆí, ÇâÈÄ ½ÅÁ¾ ÀÎÇ÷翣ÀÚ ¹ß»ý¿¡ ´ëºñÇÒ ¼ö ÀÖµµ·ÏÇÒ °ÍÀÔ´Ï´Ù.

Ÿ¹ÌÇÃ·ç ½ÃÀå - °æÀï ±¸µµ:

Ÿ¹ÌÇÃ·ç ½ÃÀåÀÇ ¾÷üµéÀº °æÀï·ÂÀ» ³ôÀÌ°í ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ ´Ù¾çÇÑ Àü·«À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â µ¶°¨ ¿¹¹æ°ú Ä¡·á¿¡ ´ëÇÑ ÀÇ·áÁø°ú ÀÏ¹Ý ´ëÁßÀÇ ÀνÄÀ» ³ôÀ̱â À§ÇÑ °­·ÂÇÑ ¸¶ÄÉÆÃ Ä·ÆäÀÎÀÌ Æ÷ÇԵ˴ϴÙ. ±â¾÷Àº ¶ÇÇÑ Á¤ºÎ ¹× º¸°Ç ±â°ü°úÀÇ ÆÄÆ®³Ê½ÊÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í µ¶°¨ À¯Çà ±â°£ ¹× ´ëÀ¯Çà½Ã Ç×¹ÙÀÌ·¯½ºÁ¦ ºñÃàÀ» À§ÇÑ °è¾àÀ» ü°áÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß ³ë·Âµµ Áß¿äÇϸç, ½ÅÁ¾ Ç÷翡 ´ëÀÀÇÒ ¼ö ÀÖ´Â Â÷¼¼´ë Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦¸¦ °³¹ßÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡°Ý Àü·«Àº ÀÇ·á ½Ã½ºÅÛÀÇ ¿¹»ê¿¡ ¸Â°Ô ¼³°èµÇ¾î ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô Æø³ÐÀº Á¢±Ù¼ºÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ ÀÇ·á ½Ã½ºÅÛÀÇ ¿¹»ê¿¡ ¸Â°Ô ¼³°èµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ÿ¹ÌÇÃ·ç ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå Ÿ¹ÌÇ÷çÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Ÿ¹ÌÇÃ·ç ¾÷°èÀÇ ¿¬±¸

Á¦5Àå Ÿ¹ÌÇÃ·ç ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå Ÿ¹ÌÇÃ·ç ½ÃÀå ±¸µµ

Á¦7Àå Ÿ¹ÌÇÃ·ç ½ÃÀå - Á¦Çüº°

Á¦8Àå Ÿ¹ÌÇÃ·ç ½ÃÀå - ¾àÁ¦ À¯Çüº°

Á¦9Àå Ÿ¹ÌÇÃ·ç ½ÃÀå - ÀûÀÀÁõº°

Á¦10Àå Ÿ¹ÌÇÃ·ç ½ÃÀå - À¯Åë ä³Îº°

Á¦11Àå Ÿ¹ÌÇÃ·ç ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - Ÿ¹ÌÇÃ·ç ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Tamiflu Market size was valued at USD 1,920.32 Million in 2023, expanding at a CAGR of 3.40% from 2024 to 2032.

Tamiflu, also known as oseltamivir, is an antiviral medication commonly used to treat and prevent influenza infections. It works by inhibiting neuraminidase enzyme, which the virus needs to spread within the respiratory system. Tamiflu is most effective in reducing flu symptoms' duration and severity when taken within the first 48 hours of symptom onset. It can also be prescribed as a preventive measure for individuals at high risk of complications from the flu. Due to its effectiveness, Tamiflu is critical in public health efforts during flu outbreaks and pandemics.

Tamiflu Market- Market Dynamics

Increasing prevalence of seasonal influenza worldwide and increased demand during the COVID-19 pandemic to propel market demand

Tamiflu (oseltamivir phosphate) is an antiviral medication indicated for the treatment of acute, uncomplicated influenza A and B, as well as swine flu (H1N1), in patients aged two weeks and older who have had flu symptoms for less than two days. It is available in both capsule and oral suspension forms. The market for Tamiflu (oseltamivir phosphate) is expected to grow over the forecast period, driven by the rising prevalence of seasonal influenza worldwide and increased demand during the COVID-19 pandemic, due to its relatively mild side effects. Additionally, the launch of generic versions of oseltamivir phosphate by many pharmaceutical companies is anticipated to further fuel market expansion. As Tamiflu is indicated for treating influenza A, B, and swine flu, the global rise in influenza cases is expected to boost the market. For instance, according to a November 2021 report by the World Health Organization, in 2020, there were 3 to 5 million cases of severe influenza illness globally.

Tamiflu Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.40% over the forecast period (2024-2032)

Based on Drug Type segmentation, generic was predicted to show maximum market share in the year 2023

Based on Dosage Form segmentation, capsules was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Tamiflu Market- Segmentation Analysis:

The Global Tamiflu Market is segmented on the basis of Dosage Form, Drug Type, Indication, Distribution Channel, and Region.

The market is divided into two categories based on Drug Type: branded and generic options. The generic segment is anticipated to dominate the market during the forecast period, largely driven by the high demand for oseltamivir phosphate in treating seasonal influenza. Generic versions of Tamiflu offer a more cost-effective solution, making them more accessible to a broader range of patients and healthcare systems. This affordability, coupled with comparable efficacy to branded drugs, contributes to the strong preference for generics, especially in regions with cost-sensitive healthcare models. Additionally, as many pharmaceutical companies have launched generic alternatives following the expiration of Tamiflu's patent, the market has seen increased competition, further driving down prices and boosting the availability of the drug.

The market is divided into two categories based on Dosage Form: capsules and suspension. The capsule segment is expected to lead the market throughout the forecast period due to its widespread preference for treating influenza. Capsules are convenient, easy to administer, and typically preferred by patients and healthcare providers alike for treating uncomplicated influenza cases. Furthermore, capsules offer more stability and have a longer shelf life compared to suspensions, making them more practical for stockpiling and distribution. Oral suspension, on the other hand, is generally reserved for patients who are unable to swallow capsules, such as young children or individuals with specific medical conditions. While it serves an important role in ensuring accessibility for these populations, the demand for oral suspension remains lower compared to capsules, reinforcing the latter's market dominance.

Tamiflu Market- Geographical Insights

The North America region is expected to dominate the Tamiflu market during the forecast period, primarily due to its significant market share and the increased stockpiling of Tamiflu in preparation for upcoming influenza seasons. For example, on December 21, 2022, the U.S. government announced that the U.S. Department of Health and Human Services (HHS), in collaboration with the Administration for Strategic Preparedness and Response (ASPR), is storing additional supplies of Tamiflu to meet rising demand during the 2022 flu season. This was achieved through the Strategic National Stockpile (SNS). The government, working with ASPR Regional Teams, will assess requests for Tamiflu distribution from the SNS, ensuring that states, territories, and tribes receive necessary support while maintaining preparedness for future pandemic influenza outbreaks.

Tamiflu Market- Competitive Landscape:

Companies in the Tamiflu market implement a range of strategies to improve their competitive position and increase market share. These include robust marketing campaigns aimed at educating healthcare providers and the public about flu prevention and treatment. Firms also prioritize partnerships with governments and health organizations to secure contracts for stockpiling antiviral medications during flu seasons or pandemics. Research and development efforts are important as well, with investments focused on creating next-generation antiviral therapies to combat emerging influenza strains. Further, pricing strategies are designed to align with healthcare system budgets while ensuring broad access for patients in need.

Recent Developments:

In December 2022, Genentech, Inc., U.S. biotechnology corporation, announced that Tamiflu (oseltamivir phosphate) was available for distribution across the U.S., enabling drug shipments to pharmacies nationwide.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TAMIFLU MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL TAMIFLU MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

GLOBAL TAMIFLU MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL TAMIFLU MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL TAMIFLU MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

GLOBAL TAMIFLU MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Tamiflu Market Overview

2. Executive Summary

3. Tamiflu Key Market Trends

4. Tamiflu Industry Study

5. Tamiflu Market: COVID-19 Impact Analysis

6. Tamiflu Market Landscape

7. Tamiflu Market - By Dosage Form

8. Tamiflu Market - By Drug Type

9. Tamiflu Market - By Indication

10. Tamiflu Market - By Distribution Channel

11. Tamiflu Market- By Geography

12. Key Vendor Analysis- Tamiflu Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â